Heska Corp (NASDAQ:HSKA) has received a consensus broker rating score of 1.25 (Strong Buy) from the four analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating and three have issued a strong buy rating on the company. Heska Corp’s rating score has improved by 28.6% from three months ago as a result of a number of analysts’ ratings changes.
Analysts have set a one year consensus price objective of $41.50 for the company and are anticipating that the company will post ($0.02) earnings per share for the current quarter, according to Zacks. Zacks has also given Heska Corp an industry rank of 73 out of 265 based on the ratings given to its competitors.
Heska Corp (NASDAQ:HSKA) traded up 0.07% during mid-day trading on Monday, reaching $28.01. 52,910 shares of the company’s stock traded hands. Heska Corp has a 52 week low of $23.22 and a 52 week high of $40.29. The stock’s 50 day moving average is $32.90 and its 200-day moving average is $33.51. The stock has a market capitalization of $184.56 million and a PE ratio of 47.56.
Heska Corp (NASDAQ:HSKA) last announced its quarterly earnings data on Thursday, March 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.17 by $0.11. The firm earned $29.80 million during the quarter, compared to analysts’ expectations of $28.31 million. On average, equities analysts anticipate that Heska Corp will post $0.73 EPS for the current year.
HSKA has been the topic of a number of recent analyst reports. B. Riley reaffirmed a “neutral” rating and issued a $33.25 target price on shares of Heska Corp in a research report on Sunday, March 6th. TheStreet raised shares of Heska Corp from a “hold” rating to a “buy” rating in a research report on Tuesday, December 29th. Finally, Zacks Investment Research cut shares of Heska Corp from a “buy” rating to a “hold” rating in a research report on Friday, March 4th.
In other news, CFO Jason A. Napolitano sold 15,000 shares of the stock in a transaction dated Wednesday, January 27th. The shares were sold at an average price of $37.00, for a total transaction of $555,000.00. Following the sale, the chief financial officer now owns 51,900 shares of the company’s stock, valued at $1,920,300. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jason A. Napolitano sold 3,700 shares of the stock in a transaction dated Tuesday, December 29th. The stock was sold at an average price of $40.03, for a total transaction of $148,111.00. Following the sale, the chief financial officer now directly owns 66,900 shares in the company, valued at approximately $2,678,007. The disclosure for this sale can be found here.
An institutional investor recently raised its position in Heska Corp stock. Acadian Asset Management raised its stake in Heska Corp (NASDAQ:HSKA) by 2.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 66,724 shares of the company’s stock after buying an additional 1,286 shares during the period. Acadian Asset Management’s holdings in Heska Corp were worth $2,580,000 as of its most recent SEC filing.
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. The Company operates in two segments: Core Companion Animal Health and Other Vaccines Pharmaceuticals and Products. The Core Companion Animal Health segment (NASDAQ:HSKA) includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.
For more information about research offerings from Zacks Investment Research, visit Zacks.com